A Study of VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection
Clinical trial NCT01832259 · COMPLETED
Trial details
- NCT number
- NCT01832259
- Sponsor
- University of Utah
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2017-02-07
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.